Targeting RAGE in sepsis

The receptor of advanced glycation endproducts (RAGE) is a multiligand receptor that upon activation causes sustained activation of multiple inflammatory pathways. Recent evidence, summarized in a review by Bopp and colleagues in this issue of Critical Care, has implicated RAGE as a potential therap...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zoelen, Marieke AD, van der Poll, Tom
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374639/
https://www.ncbi.nlm.nih.gov/pubmed/18254937
http://dx.doi.org/10.1186/cc6187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374639/
https://www.ncbi.nlm.nih.gov/pubmed/18254937
http://dx.doi.org/10.1186/cc6187

Ejemplares similares